• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙内酰脲衍生物的生物制药研究。III. 1-苯磺酰基-5,5-二苯基乙内酰脲与安替比林分子化合物的物理化学性质、溶解行为及生物利用度

Biopharmaceutical studies on hydantoin derivatives. III. Physico-chemical properties, dissolution behavior, and bioavailability of the molecular compound of 1-benzenesulfonyl-5,5-diphenylhydantoin and antipyrine.

作者信息

Fujioka H, Tan T

出版信息

J Pharmacobiodyn. 1982 Jul;5(7):475-84. doi: 10.1248/bpb1978.5.475.

DOI:10.1248/bpb1978.5.475
PMID:6982326
Abstract

Physico-chemical properties, dissolution profiles, and bioavailability of the molecular compound composed of equimolar amount of 1-benzenesulfonyl-5, 5-diphenylhydantoin (BSDH) and antipyrine were studied. The spectral and thermal analyses suggest that the intermolecular force in the molecular compound is attributed to the hydrogen bond between 3-NH of BSDH and 5-C = 0 of antipyrine. In the aqueous media, the molecular compound decomposed to the constituents and there was no interaction between them. The dissolution behavior of BSDH from the molecular compound was characteristic, the high supersaturation being present for a long time, while the dissolution of antipyrine from the molecular compound was slow and continued for a long time. The dissolution profile of the molecular compound was truly reflected on the bioavailability in dogs. With respect to BSDH, the rate and the extent of bioavailability of the molecular compound were excellent. On the other hand, the absorption of antipyrine from the molecular compound was sustained for a long time. BSDH and antipyrine had no influence one another on the intrinsic rate constant of transport through the intestinal membrane and on the pharmacokinetic constants such as the volume of distribution and the elimination rate constant.

摘要

对等摩尔量的1-苯磺酰基-5,5-二苯基乙内酰脲(BSDH)和安替比林组成的分子化合物的物理化学性质、溶出曲线和生物利用度进行了研究。光谱和热分析表明,分子化合物中的分子间力归因于BSDH的3-NH与安替比林的5-C=O之间的氢键。在水性介质中,分子化合物分解为组分,且它们之间没有相互作用。BSDH从分子化合物中的溶出行为具有特征性,长时间存在高过饱和度,而安替比林从分子化合物中的溶出缓慢且持续时间长。分子化合物的溶出曲线真实反映了在犬体内的生物利用度。对于BSDH,分子化合物的生物利用度速率和程度极佳。另一方面,安替比林从分子化合物中的吸收持续很长时间。BSDH和安替比林对通过肠膜的内在转运速率常数以及诸如分布容积和消除速率常数等药代动力学常数彼此没有影响。

相似文献

1
Biopharmaceutical studies on hydantoin derivatives. III. Physico-chemical properties, dissolution behavior, and bioavailability of the molecular compound of 1-benzenesulfonyl-5,5-diphenylhydantoin and antipyrine.乙内酰脲衍生物的生物制药研究。III. 1-苯磺酰基-5,5-二苯基乙内酰脲与安替比林分子化合物的物理化学性质、溶解行为及生物利用度
J Pharmacobiodyn. 1982 Jul;5(7):475-84. doi: 10.1248/bpb1978.5.475.
2
Biopharmaceutical studies on hydantoin derivatives. II. Pharmacokinetics and bioavailability of hydantoin derivatives in dogs.乙内酰脲衍生物的生物制药研究。II. 乙内酰脲衍生物在犬体内的药代动力学和生物利用度。
J Pharmacobiodyn. 1982 Mar;5(3):141-7. doi: 10.1248/bpb1978.5.141.
3
Aqueous solubility and dissolution rate does not adequately predict in vivo performance: a probe utilizing some N-acyloxymethyl phenytoin prodrugs.水溶性和溶解速率不能充分预测体内性能:一种利用某些N-酰氧基甲基苯妥英前药的探针。
J Pharm Sci. 1999 Aug;88(8):775-9. doi: 10.1021/js980489i.
4
Bioavailability of phenytoin: clinical pharmacokinetic and therapeutic implications.苯妥英钠的生物利用度:临床药代动力学及治疗意义
Clin Pharmacokinet. 1979 Mar-Apr;4(2):91-103. doi: 10.2165/00003088-197904020-00002.
5
Biopharmaceutical studies on hydantoin derivatives. I. Physico-chemical properties of hydantoin derivatives and their intestinal absorption.乙内酰脲衍生物的生物制药研究。I. 乙内酰脲衍生物的物理化学性质及其肠道吸收
J Pharmacobiodyn. 1981 Oct;4(10):759-70. doi: 10.1248/bpb1978.4.759.
6
Biopharmaceutical studies on hydantoin derivatives. V. Pharmacokinetics and pharmacodynamics of 5,5-diphenylhydantoin and 1-benzenesulfonyl-5,5-diphenylhydantoin.乙内酰脲衍生物的生物制药研究。V. 5,5-二苯基乙内酰脲和1-苯磺酰基-5,5-二苯基乙内酰脲的药代动力学和药效学
J Pharmacobiodyn. 1986 Mar;9(3):303-14. doi: 10.1248/bpb1978.9.303.
7
Phenytoin prodrugs V: In vivo evaluation of some water-soluble phenytoin prodrugs in dogs.苯妥英前体药物V:犬体内某些水溶性苯妥英前体药物的评价
J Pharm Sci. 1984 Aug;73(8):1080-7. doi: 10.1002/jps.2600730814.
8
Biopharmaceutical studies on hydantoin derivatives. IV. Factors affecting bioavailability of 5,5-diphenylhydantoin in dog.乙内酰脲衍生物的生物制药研究。IV. 影响犬体内5,5-二苯基乙内酰脲生物利用度的因素。
J Pharmacobiodyn. 1984 Feb;7(2):75-86. doi: 10.1248/bpb1978.7.75.
9
Dissolution behavior and bioavailability of phenytoin from a ground mixture with microcrystalline cellulose.苯妥英与微晶纤维素研磨混合物的溶出行为及生物利用度
J Pharm Sci. 1976 Oct;65(10):1484-8. doi: 10.1002/jps.2600651017.
10
Effect of formulation on dissolution and bioavailability of phenytoin tablets.剂型对苯妥英钠片溶出度和生物利用度的影响。
Pharmazie. 1980;35(10):627-9.